Abstract:Importance The overall success rate of circumferential pulmonary vein isolation (CPVI) treatment in patients with paroxysmal atrial fibrillation (AF) remains suboptimal, especially in older patients. Objective To explore the incremental benefit of low-voltage-area ablation after CPVI in older patients with paroxysmal AF. Design, Setting, and Participants This randomized clinical trial was an investigator-initiated trial to compare the efficacy of additional low-voltage-area ablation beyond CPVI vs CPVI alone in older patients with paroxysmal AF. Participants were patients aged 65 to 80 years with paroxysmal AF who were referred for catheter ablation. They were enrolled in 14 tertiary hospitals in China from April 1, 2018, to August 3, 2020, and follow-up occurred through August 15, 2021. Interventions Patients were randomized (1:1) to undergo CPVI plus low-voltage-area ablation or CPVI alone. Low-voltage areas were defined as areas with amplitude less than 0.5 mV in more than 3 adjacent points. If low-voltage areas existed, additional substrate ablation was performed in the CPVI plus group but not the CPVI alone group. Main Outcomes and Measures The primary end point of the study was freedom from atrial tachyarrhythmia as documented by electrocardiogram during a clinical visit or lasting longer than 30 seconds during Holter recordings occurring after a single ablation procedure. Results Among 438 patients who were randomized (mean [SD] age, 70.5 [4.4] years; 219 men [50%]), 24 (5.5%) did not complete the blanking period and were not included for efficacy analysis. After a median follow-up of 23 months, the recurrence rate of atrial tachyarrhythmia was significantly lower in the CPVI plus group (31/209 patients, 15%) compared with the CPVI alone group (49/205, 24%; hazard ratio [HR], 0.61; 95% CI, 0.38-0.95; P = .03). In subgroup analyses, among all patients with low-voltage area, CPVI plus substrate modification was associated with a 51% decreased risk of ATA recurrence compared with CPVI alone (HR, 0.49; 95% CI, 0.25-0.94; P = .03). Conclusions and Relevance This study found that additional low-voltage-area ablation beyond CPVI decreased the ATA recurrence in older patients with paroxysmal AF compared with CPVI alone. Our findings merit further replication by larger trials with longer follow-up. Trial Registration ClinicalTrials.gov Identifier: NCT03462628.

Effect of Atrial Pacing Therapy with Selective Pacing Algorithms on Paroxysmal Atrial Fibrillation.

The Prophylactic Effect of Special Pacing Therapy on Paroxysmal Atrial Fibrillation

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

The effect of the prevention pacing therapies to reduce the paroxysmal atrial fibrillation

Clinical evaluation of pacemaker automatic capture management and atrioventricular interval extension algorithm.

Circumferential Pulmonary Vein Isolation with Vs Without Additional Low-Voltage-Area Ablation in Older Patients with Paroxysmal Atrial Fibrillation: A Randomized Clinical Trial.

Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation

Prevention of the Initiation of Atrial Fibrillation: Mechanism and Efficacy of Different Atrial Pacing Modes

Study on the Effects of Atrial Electrophysiologic Properties and the Mechanism in Treatment of Atrial Fibrillation with Atrial Pacing

Non-saturable Ca transport in the rat intestine is via the paracellular pathway.

[Effects of Short-Term Rapid Atrial Pacing on Electrophysiological Characteristics of Atrium in Hyperthyroidism].

Status of accompaniment diseases and rhythm control in elderly patients hospitalized with nonvalvular atrial fibrillation

Interatrial Septal Pacing to Suppress Atrial Fibrillation in Patients with Dual Chamber Pacemakers: A Meta-Analysis of Randomized, Controlled Trials

The Clinical Effects of AAI Pacing and DDD Pacing in Patients with Sick Sinus Syndrome

Peripheral artery disease screening and cardiovascular disease risk assessment with the ankle-brachial index in adults.

Clinical Observation on Influence of Right Ventricular Pacing Percentage Using a Search AV Algorithm in Dual Chamber Pacemaker

Antitachycardia pacing for primary and secondary prevention of sudden cardiac death in patients with an ICD implanted

Review of Atrioventricular Node Ablation Combined with Permanent His-Purkinje Conduction System Pacing in Patients with Atrial Fibrillation with Heart Failure

Characteristics of successful termination of atrial fibrillation by atrial antitachycardia pacing in patients with cardiac implantable electronic devices

Pacemaker and Atrioventricular Junction Ablation in Patients with Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis

Synthesis of monodisperse spherical core-shell SiO 2-SrAl 2 Si 2 O 8 : Eu 2 + phosphors by hydrothermal homogeneous precipitation method